Ricalde, Alvin M.

HRN: 22-20-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2025
CEFTRIAXONE 1G (VIAL)
10/08/2025
10/14/2025
IVTT
2g
OD
Urinary Tract Infection
Waiting Final Action 
10/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/09/2025
10/09/2025
IV
Loading Dose
Stat Dose
Sepsis Sec To Complicated UTI
Waiting Final Action 
10/09/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/09/2025
10/15/2025
IV
2.25g
Q8
Sepsis Sec To Complicated Uti
Waiting Final Action 
10/10/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/10/2025
10/16/2025
IV
2.25g
Q6
Sepsis Sec To Complicated Uti
Waiting Final Action 
10/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/10/2025
10/16/2025
IV
500mg
IV
Sepsis Sec To Complicated Uti
Waiting Final Action 
10/17/2025
CEFTRIAXONE 1G (VIAL)
10/17/2025
10/23/2025
IV
2g
Od
Complicated Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: